Patent · US Expired

Method for isolating a novel receptor for .alpha.4 integrins

US5599676A · kind A · utility

21Cited by
0References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 14, 1994
Grant dateFeb 4, 1997
Priority date
Expiry dateOct 14, 2014

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present invention is directed to a method for isolating a novel receptor for .alpha.4 integrins such as VLA-4, that is distinct from VCAM-1 and from fibronectin. Isolated nucleic acids encoding the receptor and antibodies to the receptor are also provided. The invention is also directed to pharmaceutical compositions, and methods of treating disorders involving an undesirable inflammatory or immune response by administering the VLA-4 receptor of the invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.